Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under... Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma. Show more
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – Exelixis, Inc. (Nasdaq: EXEL) announced today that its third quarter 2024 financial results will be released on Tuesday...
Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No. 22-00228 (Consolidated), the U.S...
Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the companies have entered into a clinical development...
ONCOLOGY COMMERCIALIZATION LEADER P.J. HALEY TO JOIN NETRAMARK BOARD OF DIRECTORS Canada NewsWire TORONTO, Oct. 9, 2024 TORONTO, Oct. 9, 2024 /CNW/ - NetraMark Holdings Inc. (the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.14 | 12.1894409938 | 25.76 | 29.7499 | 25.76 | 3370108 | 28.51164081 | CS |
4 | 2.1 | 7.83582089552 | 26.8 | 29.7499 | 25.174 | 2098879 | 27.10046368 | CS |
12 | 5.81 | 25.1624079688 | 23.09 | 29.7499 | 22.8 | 1985172 | 26.34522995 | CS |
26 | 5.9 | 25.652173913 | 23 | 29.7499 | 20.14 | 1873559 | 24.15922001 | CS |
52 | 7.12 | 32.6905417815 | 21.78 | 29.7499 | 18.64 | 2077449 | 22.99270871 | CS |
156 | 7.25 | 33.4872979215 | 21.65 | 29.7499 | 14.87 | 2311722 | 20.12305502 | CS |
260 | 11.87 | 69.7005284792 | 17.03 | 29.7499 | 13.67 | 2401778 | 20.41987297 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.